MDGL · All filings · Read this filing
What changed 10-Q
Item 1A. Risk Factors
2024-10-31 compared with 2024-08-07 · 2 added, 2 removed, 50 unchanged (7% of the section changed)
9 unchanged sentences
There are numerous examples of failures to meet high expectations of market potential, including by pharmaceutical companies with more experience and resources than us.
−Removed: We are in the process of building our commercial organization and hiring our U.S.
−Removed: sales force and will need to refine and further develop our commercial organization in order to successfully commercialize Rezdiffra.
+Added: We have built our commercial organization and have hired our U.S.
+Added: sales force and will continue to refine and further develop our commercial infrastructure in order to successfully commercialize Rezdiffra.
We expect that the initial commercial success of Rezdiffra for the treatment of NASH will depend on many factors, including the following:
39 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.